Company intelligence / Profile preview

Vector-Vita

Novosibirsk, Novosibirsk Oblast, Russia
Ownership
Private
Development stage
Other
01

Overview

Vector-Vita is a Russian biotechnology company based in the Novosibirsk scientific hub that specializes in the development and production of advanced silver-based nanotechnologies. The company's core business revolves around its proprietary "cluster silver" platform, which produces stabilized silver nanoparticles marketed under the brand name Argovit. These formulations exhibit broad-spectrum antimicrobial, antiviral, and antifungal properties and are utilized in pharmaceutical, veterinary, and cosmetic products. Vector-Vita provides pharmaceutical substances for the treatment of skin and mucous membrane infections, as well as dietary supplements and specialized veterinary treatments for gastrointestinal issues. The company leverages its research and manufacturing base in Koltsovo to supply silver-based active ingredients to both domestic and international markets.

Therapeutic areas
GastroenterologyDermatologyInfectious Diseases
Modalities
NanoparticleSmall molecule
Industry
Biotech
02

Drug pipeline

1 asset

Argovit

Unknown
03

Partnerships

Siberian Branch of the Russian Academy of SciencesState Research Center of Virology and Biotechnology VECTOR

Beyond the preview

Go deeper on Vector-Vita.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vector-Vita.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call